1. Home
  2. CZNC vs PGEN Comparison

CZNC vs PGEN Comparison

Compare CZNC & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens & Northern Corp

CZNC

Citizens & Northern Corp

HOLD

Current Price

$20.94

Market Cap

377.9M

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZNC
PGEN
Founded
1864
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
377.9M
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CZNC
PGEN
Price
$20.94
$4.38
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$22.00
$7.67
AVG Volume (30 Days)
78.8K
4.7M
Earning Date
01-22-2026
11-13-2025
Dividend Yield
5.33%
N/A
EPS Growth
22.09
N/A
EPS
1.75
N/A
Revenue
$109,632,000.00
$6,309,000.00
Revenue This Year
$5.72
$342.78
Revenue Next Year
$7.18
$478.46
P/E Ratio
$11.98
N/A
Revenue Growth
7.59
59.20
52 Week Low
$17.85
$0.69
52 Week High
$22.68
$5.23

Technical Indicators

Market Signals
Indicator
CZNC
PGEN
Relative Strength Index (RSI) 54.07 63.06
Support Level $21.76 $3.64
Resistance Level $22.25 $3.75
Average True Range (ATR) 0.51 0.27
MACD -0.00 0.09
Stochastic Oscillator 43.59 85.71

Price Performance

Historical Comparison
CZNC
PGEN

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: